Monthly Writings

Evaluations and reviews of the latest in the field.

The Buy vs Build Dilemma of Digital Health

After reading this article, you will be able to define the key decision elements to determine the buy vs build decision for digital health projects.

SUMMARY:

  • The optimal selection approach varies by the health care organization.

  • The 3 major options are: Purchase a complete product; Configure an existing tool; or Build a tool internally.

  • An objective decision-making process can help.


Advantages and Disadvantages

  • Advantages and disadvantages of each option vary based on:

    • The type of problem the tool will address (a specific unique problem to a system vs universal problem)

    • Characteristics of the health care system

OPTION 3: HYBRID MODEL:

  • Co-development with private vendor

  • Purchase a foundational infrastructure and build proprietary analytics and workflows on top of it.

  • Digital tool can be tailored to meet system-specific needs

  • Easier adoption within the system

  • Licensing ability

Build vs Buy Decision Framework

  • Strategic Importance

    • What type of problem will the tool address (1 specific problem vs universal problem)?

    • How quickly does the tool need to scale and spread across the system?

    • Will the tool provide a core strategic differentiator?

    • Will it foster a culture of innovation?

  • Organizational Internal Capabilities:

    • Informatics expertise

    • Engineering resources

    • Data science talent

    • Product management skills

    • Regulatory expertise

    • Long-term maintenance (upgrades & user support) for 5-10 years

  •  Financial Analysis for Total Cost of Ownership

    • Development costs

    • Integration costs

    • Cybersecurity

    • Clinical Validation

    • Regulatory requirements

    • Maintenance staff

    • Opportunity cost

    • Upgrades

    • Liability 

  • Workflow Integration and User Adoption

    • Amount of workflow alterations required

    • Clinical acceptance

    • Training

    • Change management needs

CONCLUSIONS:

  • Although several considerations need to be made before a final decision, one important question remains:

    • If the capability is strategically unique with proprietary AI algorithms, differentiated workflows within a unique patient population AND the solution will improve outcomes to a degree to justify the workflow and resource investment – CONSIDER BUILDING

    • If the capability is largely already commoditized and not worth the workflow disruption required for adoption – CONSIDER BUYING

The key question will be whether the solution achieves the desired result enough to justify the system-wide workflow disruption for development or not.

Once the problem is identified, a build or buy assessment including all available solutions should occur.

An enterprise decision based on several factors on TOTAL value rather than acquisition cost must then be made.

Let’s have a brief chat to discuss your unique situation

Erkan Hassan